600422 昆药集团
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.10010.9699.3677.84710.996
总资产报酬率 ROA (%)2.1885.2044.9774.1825.967
投入资产回报率 ROIC (%)3.8638.8517.3885.8638.590

边际利润分析
销售毛利率 (%)39.41943.46046.61141.51641.301
营业利润率 (%)7.98311.0409.3676.0037.682
息税前利润/营业总收入 (%)8.68711.2909.3466.2258.130
净利润/营业总收入 (%)6.8078.9427.6234.6546.218

收益指标分析
经营活动净收益/利润总额(%)58.36191.08497.45093.56067.235
价值变动净收益/利润总额(%)32.2632.3382.3323.49023.712
营业外收支净额/利润总额(%)-0.2320.752-0.419-4.161-0.437

偿债能力分析
流动比率 (X)1.9311.5582.1081.7401.773
速动比率 (X)1.5841.2781.6501.3081.233
资产负债率 (%)42.89846.50635.30645.47844.447
带息债务/全部投入资本 (%)21.92016.82112.64220.59219.103
股东权益/带息债务 (%)334.771465.404654.239360.966393.235
股东权益/负债合计 (%)103.07689.575151.176116.170121.017
利息保障倍数 (X)12.03167.811512.31913.45916.905

营运能力分析
应收账款周转天数 (天)168.703119.724111.20093.51171.025
存货周转天数 (天)139.311125.502138.091132.455133.796